Latest filing published 09 Jan 2023 for NEPHROS INC.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Tom Gwydir: trading record in brief
Tom Gwydir is a declared insider of Nephros Inc (board member), with filings sourced from SEC (Form 4). Between 16 December 2019 and 5 January 2023, the trades on record add up to 5 filings.
No open-market sale appears; the market trades are 1 purchase worth €33k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 4 share grants.
On 9 January 2023 came the latest disclosure, a share grant in Nephros Inc. The clock since the last published purchase (19 August 2021) now reads 1,909 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Tom Gwydir
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 27,613 shares0Common StockSEC:0001062993-23-000719:0
- 4,582 shares0Common StockSEC:0001437749-21-028835:0
- 5,000 shares@ US$7.64100.0% of flowCommon StockSEC:0000914190-21-000284:0Canonical exit: 16 Nov 2021 (T+90)
3 of 3 declarations
